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~ Results of Stontlng In Patients Aged 75 Coronary 
Ysars or Older 
J, DeGro0orio, L, Finci, Y Kobayasht, D, Rolmors. L, DiFrancosco, 
C, DiMsrio, A, Colombo, Centre CaDre Colunlb¢/~, Milan, Italy 
To a~ogs the Directs of coronery stoat impt,nfBtton in the elderly, the results 
of coronery ~tontlnO podormod in 137 gonsocutiva patients ~god _:75 years 
wore compared Io II~o results obtained in a consecutive cohort of 2.551 
younger patients Procedure secedes was defined o6 any patient who l~ad 
rovs~ogleltzafion rooutling in ~30% roslduel ~lonosi6 without death, MI, 
or ~morgon¢y CABS, All patients wore treated wttl~ antiplatolot thgropy; 
none relieved oral anli¢oagulation, Follow.up quantitative artg(ography was 
obtained allot 6 months or Defiler when clinlcelly indicat0d, 
R~ult~: are as follows', 
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Conclusions: Despite improvements in stont technology and post proc@ 
dural manogomont, shod term complications (dgath and CABG) and cardiac 
events during follow-up are hlgl~or In older patients. Further Improvements 
are necessary to optimize the results in tl~ts higl~ risk group, 
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~ Coronary StenUng In Elderly Patients: Clinical and 
Anglographlc Implications 
F. Alfonso, L. Azcnna, R, Hernandez, A. Fernandez-Ortiz, J. Goicolea, 
J. Escaned C. Bar~uelos, C, Mocaya, San CoHos Unwersity Hospital. 
Madrid, Spa~n 
Background: Coronary steering (ST) is currently being used in many pa o 
tients (P) during coronary angioplasty (PTCA) However, the clinical and 
ang=ograph=c imphcat¢ons of ST in orderly P, an important subgroup el P 
undergoing PTCA, remain unknown. 
Methods: Accordingly, the results of ST in 262 consecutive P - 65 years 
(449 lesions with ST (Group I) (mean age 71 :t. 5 years) were compared 
with those obtained in 412 consecutive P .  65 years (689 lesions with ST) 
(Group II) (mean age 53 ± 8 years), 
Results: More P in Group I were female (25% vs 10%, p . 0.001), had 
hypertension (49% vs 42%, p .  0.05) and diabetes (25% vs 16%, p • 0.01). 
In addition, more P in Group I presented with unstable angina (77% vs 70%, 
p - 0.05), had a prior history of by.pass surgery (13% vs 5%, p ~: 0.001) or 
congestive heart failure (6% vs 2%, p < 0.01), Lesion distribution within the 
coronary tree was similar in both groups except for a higher number of lesions 
on vein gratis (9% vs 3%. p .  0.01) in Group I. Adverse lesion characteristics 
including calcitied (18% vs 12%, p ~ 0.05), eccentric (90% vs 81%, p . 
0.001), or B2-C lesions (73% vs 66%, p .  0.05) w~.r~ more trequent in Group 
I. Complete revascularization was more frequently achieved in Group II (66% 
vs 53%, p -: 0.05). Procedural success was similar in both groups (93% in 
Group I vs 95% in Group II, NS), but major complications (6.9% vs 3.8%, p 
0.05), including hosp¢tal mortality (4.8% vs 1.5%, p ~ 0.01), were higher 
• n Group I. Vascular complications were also more Irequent (5% vs 2%, p • 
0.05) in Group I. On actuarial analysis event-tree survival (death, myocardial 
infarction or repeat revacularization) at 12 moths was similar (Mantel-Cox) in 
both groups (81% Group II vs 80% Group I, NS). 
Conclusion: ST constitutes an attractive strategy for coronary interven- 
tions in the elderly. Although the adverse qlinical and anatomic ch'~racteristics 
of these P determine a higher initial risk, the mid-term clinical outcome of P 
with successtut procedures is similar to that obtained in younger P. 
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8~9-6 ~ Long Term Survival After Coronary Artery Bypass 
Grsfting: A Coronary Artery Surgery Study (CASS) 
Registry Study 
W,O, Myers, E,H, Blackstono, K D~v,s Matshflold Clinic, Mar~htiol¢/ Wl, 
University ~f Al~]bam~, Birmingham, AL, USA 
Objectives: To ollow the force o! clinical, anglo ~nd demographic trait5 on 
Into 8grviv~l of Coronary AriDly Sulgory ~$tgdy (CASS) patients lallowin 9 
coronary bypass (CABG) and tarred.co Ha_~,ard Fol~fion aeaty~is to CA$$ 
survival data, 
MolhOd~: Patients wore roeC.'ll~d by m~ll 5ol~oy with 94% 1~5p0¢1~: J~y 
Nali0nsl Death Index, villi ststg~ was obtained in 093% (n ~ 8~1)  with a 
moan follow.up of 16 years, Cox proportional h~rd  and Blackstone Hata~ 
Function regressions wore o~0d to assos~ oltect~ ol prool~r~tivo Ira_its. 
Results: Ninety percent of patients worn alive at 5, 74% at 10 aN 56% at 
t 5 yearn, Of those ago 6.5 and age 75 at operation, 74% ~nd 59% WOlD Iwing 
at 10 years and 54% ~nd 33% at 16 yoa~ (now age gO), so,viva! exc.e~jing 
tim matched U,S, population, Hazard Function laUs rapidly alt6r CABS to 
9 to 12 month~, th*]n n~os, doubling by 15 year~, Yoon 9 patients, below 
rt~o 35, llad Iowol tat~ survival, Th0 time-segmented Oaw m~! (dcwded at 
time suggested by the Hazard Function) tdontiliod Italia ShOw!n9 pledimiv~ 
powgr omly, tllrough0ut, and !ate. F~m~!a sow, small body sudace, i~,:i~mm 
symptoms, and emergency status attoctod sulvival early, Heavier weight, 
infar~t(a), diuretics, diebofos, smoking, !oft main and LAD stonosis, and use 
of vein gratis only, increased hazard !ate only. 
Conclusions: Tiptoe are still Iossons Item the CASS database. CABS 
m the elderly is suppad0d by the long lo!low-up el our patients age 75 
at operation. Time.segmented Cox ana!ysis and Hazard Function analysis 
separate baseline variables into those which predict early modallty and those 
which predict long survival. 
New Understandings of Antlcoagulatlon 
During Unstable Angina 
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~-~ Heparln Dosing and Outcome In Acute Coronary 
Syndromes: The GUSTO-lib Experience 
I.C. Gilchnst. C.B. Granger, T.D. Thompson, R.M. CalilL Pennsylvania State 
University. Hershey. PA: The Duke Clinical Research Institute. Durham. NC. 
USA 
Background: Despite understanding several el the factors that determine 
hepann consumption, its dosing varies greatly among patients with acute 
coronary syndromes. Whether this is associated with patient outcome re- 
mains poorly understood. 
Methods: Baseline demographics, 12-hour aPTT, weight-indexed hepann 
rate and 30-day outcome (death or reintarction) were analyzed in 5335 
patients treated with heparin in the GUSTO-lib trial. Probability of outcome 
was determined based on the hepaan rate and adjusted based on baseline 
characteristics, subgroup (ST elevated/depressed MI, or un.~table angina). 
and aPTT results. 
Results: Unadjusted relationship between weight-indexed hepann rate 
and 30-day outcomes are displayed in the table, A nadir of mortality was 
noted at 14 U/kg/h of heparin with increased mortality at higher and lower 
dosages. Adjusting for subgroup strengthens these effects. However, after 
adjustment for differences in baseline characteristics and the 12-hour aPl-l". 
there appears to be no significant, independent weight-indexed heparin el- 
fact. 
30*day Outcomes ~ 2 p 
Mortahty 93 0 054 
Reinfarclion 0.26 0.610 
Death or relnfarction 7 58 0 056 
Conclusions: Hepnnn consumption is associated with outcome in acute 
coronan] syndromes, but this effect appears to depend on baseline patient 
characteristics and aPTT levels. 
